Key Highlights

  • INLIF Limited (NASDAQ:INLF) traded at USD 0.4267 on November 12, 2026, down 39.03%, on about 5.57 million shares, after falling about 22% in after-hours trading the previous evening.
  • On November 11 its Subsidiary announced a three-year procurement and Supply framework with Heng Sheng Group planned at USD 30 million, and the stock rose more than 27% during that session.
  • The amounts in the framework are preliminary, not minimum purchase commitments, and are spread across six phases of about USD 5 million each.
  • In October the company sold about USD 3.75 million of stock and pre-funded warrants at USD 1.60, with warrants that carry a one-time exercise price reset.

A Headline Rally That Did Not Hold

INLIF Limited (NASDAQ:INLF) makes manipulator arms for injection molding machines and automation and testing equipment for the lithium battery and energy storage industries through its Chinese subsidiary, and it entered humanoid robotics in June. On the morning of November 11 it announced that the subsidiary had signed a three-year framework with Heng Sheng Group, planned at USD 30 million and split into six phases of about USD 5 million every six months. The shares opened near USD 0.88 against a prior close of about USD 0.55 and traded as high as USD 0.96. The gain faded through the day and the stock fell about 22% after hours, before dropping a further 39.03% on November 12. The framework itself states that the amounts are preliminary and do not represent minimum commitments, which likely limited how much value traders were willing to assign to it, although no company statement explains the decline.

Dilution Overhang From the October Raise

Share supply is a second pressure point. On October 19 the company priced a registered direct offering of about USD 3.75 million, consisting of 435,000 Class A shares and pre-funded warrants for up to 1,908,750 shares at USD 1.60, each with Series A, B and C warrants. The Series A and B warrants, each covering up to 2,343,750 shares, carry a one-time reset of the exercise price on the 20th trading day after issuance, a feature that can lower the price at which new shares are created when the stock is weak. Shareholders also approved an increase in authorised Capital to 8 billion Class A shares in September, and a 1-for-200 share combination took effect in July. With the stock now well below the October offering price, the market appears to be discounting further issuance, an interpretation rather than a stated cause.

Fundamentals Look Stronger Than the Price

The reported numbers are better than the share price implies. For the six months to June 30, 2026, Revenue rose 26.01% to USD 12.94 million, gross Margin was 35.95% and Net Income was USD 1.01 million against a loss a year earlier. Cash rose to USD 45.47 million at June 30 from USD 6.72 million at the end of 2025, after financing inflows of USD 56.25 million. Even so, the screen shows trailing diluted losses of USD 577.64 per share, a figure distorted by the share combination, and a Market Value of about USD 650,840. Relative Volume of just 0.04 shows how large recent trading has been. Investors should watch whether the first USD 5 million phase converts into orders, the Warrant reset level and Nasdaq bid price compliance with the stock below USD 1.00.

Where Things Stand

INLIF Limited (NASDAQ:INLF) fell 39.03% to USD 0.4267 on November 12, 2026 as a rally on its USD 30 million Heng Sheng framework reversed. The framework is non-binding in amount, and warrant resets from the October raise add dilution risk. First-half profit and cash look solid, so actual orders and share issuance will decide the next move.